M. Javad Aman
Has grant
Chief Scientific Officer
United StatesResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
M. Javad Aman is the Chief Scientific Officer at Integrated Biotherapeutics, Inc. in the United States. His research focuses on innovative therapeutic strategies, including the development of inhibitors for RET solvent-front mutants and treatments for viral infections such as Ebola and Zika virus. Additionally, he has contributed to advancements in therapies for Argentine hemorrhagic fever using monoclonal antibodies.
Recent Grants
Grant: Close
Infection Site Targeted Antitoxin Antibody (ISTAb) against Clostridium difficile
Open Date: 2015-02-01
Close Date: 2016-01-31
Grant: Close
Multivalent Toxoid Vaccine for Prevention of S. aureus Invasive Diseases
Open Date: 2015-01-01
Close Date: 2019-12-31
Grant: Close
Multivalent Toxoid Vaccine for Prevention of S. aureus Invasive Diseases
Open Date: 2014-08-01
Close Date: 2015-07-31
Grant: Close
Development of Pan-Filovirus Monoclonal Antibodies
Open Date: 2013-07-01
Close Date: 2017-01-01
Grant: Close
Multi-specific Antibody Therapy by targeting S. aureus toxins and polysaccharides
Open Date: 2012-06-29
Close Date: 2015-05-31
Articles (4)
Year:
2023
Year:
2021
Year:
2021
Year:
2020
Collaborators (2)
Michal Toborek
University of Miami Miller School of Medicine
Herman O. Sintim
-
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.